MDxHealth SA received a notice from Nasdaq indicating non-compliance with the $1.00 minimum bid price requirement after its ordinary shares closed below $1.00 for 30 consecutive trading days. The company has a 180-day compliance period ending December 28, 2026, to regain compliance by meeting the $1.00 threshold for 10 consecutive trading days. MDxHealth SA is a molecular diagnostics company providing clinical testing services.
